INTRODUCTION
The long-chain fatty acyl-CoA synthetase (EC 6.2.1.3) reaction is the first step in most metabolic conversions of fatty acids. Although this enzyme has been studied in platelets (Farstad & Sander, 1971; Farstad et al., 1973; Berge et al., 1980; Wilson et al., 1982; Neufeld et al., 1984; Laposata et al., 1985; Bakken & Farstad, 1989) , little is known about whether its specificity for fatty acids is of importance for their incorporation into phospholipids. It has been suggested that platelets possess an acyl-CoA synthetase which is specific for arachidonic acid and other prostanoid precursors (Wilson et al., 1982; Neufeld et al., 1984; Laposata et al., 1985) . We found that palmitoyl-CoA and arachidonoyl-CoA synthetase activities in human platelet were identically distributed in subcellular fractions and were heatinactivated to the same extent (Bakken & Farstad, 1989) , in spite of the observation that arachidonic acid was selectively incorporated into the dense tubular system/open canalicular system (Laposata et al., 1987) . It is therefore of special interest to study the conditions for the formation of acyl-CoA by the arachidonoyl-CoA ('specific') synthetase and by the palmitoylCoA ('unspecific') synthetase.
The present work reports similar Km values of the synthetase in platelet lysates for three substrates of the synthetase reaction (CoA, ATP and fatty acids), using ten different fatty acids including arachidonic acid and palmitic acid. Furthermore, attempts to separate the alleged arachidonoyl-and palmitoylCoA synthetases using several chromatographic methods were unsuccessful. We conclude that there is only one long-chain acylCoA synthetase in human platelets.
MATERIALS AND METHODS
[1-'4C]Lauric acid (C12:0) (specific radioactivity 36.3 mCi/ mmol), [1-'4C] palmitic acid (C16:0) (58 mCi/mmol), [1-'4C1- stearic acid (C18:0) (57 mCi/mmol), [1-_4C] oleic acid (C18:1, -9) (56.7 mCi/mmol), [1-_4C] linoleic acid (C18:2,n-6) (58 mCi/ mmol), [1l_4C] (9,12,15)-linolenic acid (C18:3,n-3) (56.2 mCi/ mmol), [1_-4C] arachidonic acid (C20:4,n-6) (60.1 mCi/mmol), and [1_1-4C]eicosa-5,8,11,14,17-pentaenoic acid (EPA, C20:5,n-3) (55 mCi/mmol) were purchased from Amersham International (Amersham, Bucks., U.K.). [1-_4C] 7, 10, 13, 16, aenoic acid (DHA, C22:6,n-3) (55 mCi/mmol) was purchased from New England Nuclear (Boston, MA, U.S.A.), and [1-14C]-myristic acid (C14:0) (55 mCi/mmol) was from Commissariat a l'Energie Atomique (CEA, Saclay, France). Scint-Hei 3 from Koch-Light Laboratories (Colnbrook, Slough, Berks., U.K.) was used as scintillator. ATP, CoA, fatty acids (of the same length and saturation as their radioactive counterparts), dithiothreitol (DTT), Triton X-100, inorganic pyrophosphatase, EDTA and Hepes were purchased from Sigma (St. Louis, MO, U.S.A.). Unlabelled DHA was from Aldrich, Steinheim, Germany. All other chemicals were ofthe highest purity commercially available. T.l.c. plates (silica gel 60; Merck, Darmstadt, Germany) were used for the t.l.c. studies. Hydroxyapatite 'High Resolution' was from Fluka AG, Buchs, Switzerland. DEAESepharose Fast Flow, Sephacryl S-200 HR, activated thiolSepharose 4B and Sephadex G-100 were from Pharmacia LKB Biotechnology, Uppsala, Sweden. Ultrogel AcA 34 was from Reactifs IBF, Villeneuve-la-Garenne, France.
Preparation of platelet lysates
Blood platelet lysates and subcellular fractions of platelets were prepared from samples from healthy blood donors, as described previously (Holmsen et al., 1977; Bakken & Farstad, 1989) .
For the chromatography experiments, approx. 60 x 109 platelets were isolated and washed as described. The platelets were resuspended in 9 ml of a 20 mM-potassium phosphate buffer (pH 7.45) containing 5 mM-DTT and 50,uM-ATP. Triton X-100 was added to a final concentration of 2 mm to lyse the platelets Vol. 274
Abbreviations used: EPA, eicosapentaenoic acid (C20:5,n-3); DHA, docosahexaenoic acid (C22:6,n-3); DTT, dithiothreitol (Tanaka et al., 1979) . The suspension was kept on ice for 75 min and then centrifuged at 100000 gmax at 4°C in a Beckman L8 ultracentrifuge for 60 min. The supernatant (Triton X-100 extract) was used in the different chromatography systems. All chromatography was done at 4 'C.
Hydroxyapatite chromatography A 7 ml portion of the Triton X-100 extract was applied to a 1.36 cm x 5.2 cm hydroxyapatite column, equilibrated with buffer A-20 (containing 20 mM-potassium phosphate, 5 mM-DTT, 2 mM-Triton X-100 and 50 ,tM-ATP, pH 7.45). The column was then eluted with 30 ml of the same buffer, and thereafter with 50 ml of A-80 (as above but with 80 mM-potassium phosphate), and then with a 10 ml gradient buffer from 80 to 300 mmpotassium phosphate, and finally with 40 ml of buffer A-300 (i.e. containing 300 mM-potassium phosphate). The flow rate was 30 ml/h; fractions of 2 ml were collected. DEAE-Sepharose Fast Flow chromatography A 7.3 ml portion of the Triton X-100 extract was applied to a 94 ml column (2.6 cm x 17.7 cm) of DEAE-Sepharose Fast Flow, equilibrated with buffer A-20. The column was eluted with 150 ml of the same buffer, and thereafter with 160 ml of buffer A-80 followed by a gradient buffer increasing from A-80 to A-300. Finally the column was eluted with 175 ml of buffer A-300. The flow rate was 86 ml/h; fractions of 4.3 ml were collected. Fractions containing enzyme activity were combined and concentrated (from 22.5 to 6.5 ml) by ultrafiltration using a Diaflo membrane filter PM-10 (Amicon).
Sephacryl S-200 HR chromatography
The above concentrated solution was applied to a 136 ml Sephacryl S-200 HR column (1.6 cm x 68 cm) which was eluted with buffer A-80. The flow rate was 32 ml/h; fractions of 4.0 ml were collected. The fractions containing enzyme activity were combined and dialysed for 3.5 h against 25 mM-potassium phosphate/2 mM-Triton X-100 (pH 7.45). The buffer was changed nine or ten times.
CoA-Sepharose 4B chromatography CoA-Sepharose 4B was prepared from activated thiolSepharose 4B according to Kameda et al. (1985) . A 4 ml portion of the Triton X-100 extract (omitting ATP and DTT) was applied to a 14.5 ml CoA-Sepharose 4B column (1.6 cm x 7.3 cm) equilibrated with a 25 mM-potassium phosphate buffer (pH 7.45) containing 2 mM-Triton X-100. The column was eluted with 65 ml of the same buffer, followed by a 60 ml gradient of 0-0.7 M-KCI in the equilibration buffer. The flow rate was 15 ml/h; fractions of 2 ml were collected. Sephadex G-100 chromatography A 3 ml portion of the Triton X-100 extract was applied to a 115 ml (1.36 cm x 79.2 cm) Sephadex G-100 column. Elution was with buffer B-20 [20 mM-potassium phosphate (pH 7.45) containing 1 mM-ATP, 5 mM-DTT and 2 mM-Triton X-100], followed by buffer B-80 (as above but containing 80 mmpotassium phosphate). The flow rate was 10.8 ml/h; fractions of 3.6 ml were collected. Recovery of activity was 670% for both ['4C] (Berge et al., 1981) , all fatty acid substrates were presented in a mixed micellar form. This ensured identical assay conditions. Incubations were carried out at 37°C for 3 min, which is within the range giving a constant reaction rate (Wilson et al., 1982; Bakken, 1986) . The assay relies on heptane extraction of unreacted fatty acids and the insolubility of acyl-CoAs in heptane (Bar-Tana et al., 1971) . Usually five extractions were performed.
For each extraction the volume of the aqueous phase was reduced. This was taken into account when calculating the activity of the enzyme (Bakken, 1986) . Using lysate, some activity was found in the absence of added ATP or CoA due to the endogenous content of these components, in agreement with previous findings (Farstad & Sander, 1971 (Hauser & Eichberg, 1975) to separate unreacted 14C-labelled fatty acids from phospholipids. (Radioactivity was measured with RITA, and a radio-t.l.c. program from Nuclear Interface.) The heptane-washed aqueous phase was thereafter extracted by chloroform/methanol (2: 1, v/v) (Bligh & Dyer, 1959) , and developed on t.l.c. as described above.
Working solutions of 1.5 mm fatty acids were prepared. The saturated fatty acids were dissolved in 5-25 mM-KOH, except for stearic acid, which was dissolved in 5.6 M-ethanol and 25 mm-KOH. All six unsaturated fatty acids were dissolved in 450 mmethanol in 5 mM-KOH. The polyunsaturated fatty acids were kept at -80°C in the dark in an atmosphere of N2 for not more than 1 month. Addition of antioxidants to the fatty acid suspensions was omitted to avoid any possible unwanted reactions and inhibitions during acyl-CoA formation.
To make sure that the ethanol in the incubation mixture did not inhibit the acyl-CoA synthetase reaction, an experiment with palmitate as radioactive substrate and increasing amounts of ethanol in the incubation mixtures was performed. The formation of palmitoyl-CoA was not influenced by ethanol at concentrations below 130 mm, which is well above the concentration of ethanol in our assays (45 mM) investigating the unsaturated fatty acids.
Palmitoyl-and arachidonoyl-CoA synthetase in human platelets
The specific radioactivities of the fatty acid substrates were 800-1000 c.p.m./nmol when counted in a Packard Tri-Carb spectrometer (model 2450).
The formation ofacyl-CoA from the endogenous non-esterified fatty acids in blood platelet lysates was analysed by an h.p.l.c. method (Ingebretsen et al., 1982a) . The activity was calculated by measurement of the AMP formed in the incubation mixture over 3 min, without addition of fatty acids. P1P5-Diadenosine 5'-pentaphosphate was added to the incubation medium to inhibit the adenylate kinase in the lysate (Lienhard & Secemski, 1973) . The reaction was stopped by the addition of HC104, and after centrifugation the supernatant was neutralized with K2HP04 before injection on to the chromatograph. The calculated value of acyl-CoA formation was about 3 nmol/min per 109 platelets, giving a concentration of 2.8 /tM endogenously formed acyl-CoA in the incubation mixture within 3 min.
Calculations
The apparent Km values of substrates for acyl-CoA synthetase were calculated from the Lineweaver-Burk plot, or were derived directly from the Michaelis-Menten saturation curves if the Lineweaver-Burk plots were non-linear. All straight lines in the different plots have been calculated by the least-squares method.
The maximum activity of acyl-CoA synthetase was measured at concentrations approx. 10 times the Km for each of the three substrates. The heptane-extracted aqueous phase was re-extracted with methanol/chloroform (2:1, v/v). T.l.c. of chloroform layer showed no spot of 14C-labelled phospholipids (results not shown). Hydrolysis of newly formed acyl-CoA did not take place under the incubation conditions used, since acyl-CoA hydrolase activity is strongly inhibited in the presence of 10 mM-MgCl2 (Berge & Farstad, 1978) , and the presence of 1.6 mM-Triton X-100 will leave no free acyl-CoA, which is the substrate for the long-chain acyl-CoA hydrolase (Berge et al., 1981) .
Activity of acyl-CoA synthetase and apparent K. values with different substrates
To study 'unspecific' and 'specific' acyl-CoA synthetase activities in human platelets (Wilson et al., 1982; Neufeld et al., 1984; Laposata et al., 1985) , determinations of apparent Km values for all substrates of the acyl-CoA synthetase reaction were performed. to the high content of ethanol in the incubation mixture), indicating the presence of two active sites for CoA on the enzyme. For both ATP and fatty acids as variable substrate the Hill coefficient was 0.8-1.1 for all fatty acids. Thus-the optimal conditions for palmitoyl-CoA and arachidonoyl-CoA synthetase activities as well as activities for other long-chain fatty acids are identical in human platelet lysates. Fig. 2 shows the maximal activity of acyl-CoA synthetase with different fatty acids as substrates, given as means in lysates from 2-8 different blood donors. Also, the activities in a P fraction (dense-tubular-enriched fraction) and an M fraction (mitochondria-enriched fraction) are shown. The pattern of activity was almost identical in whole homogenate and in the M and P fractions, with one peak for palmitate and one peak for arachidonate.
Fatty acid specificity of platelet acyl-CoA synthetase To study differences in the specificity of the synthetase reaction with palmitic acid or arachidonic acid as the fatty acid substrate, two sets of experiments were performed.
First, inhibition was studied in two experiments with both the 14C-labelled fatty acid substrate and the inhibitory non-labelled fatty acid at concentrations close to their apparent Km values. Fig. 3 shows that the formation of [14C]palmitoyl-CoA was inhibited by the presence of any of the unsaturated fatty acids tested, in the order C18.3 > C22:6 > C18:1 > C18:2 > C20:5 > C20:4-However, the difference between the last three fatty acids was small. The inhibition was not of a clear competitive type, but rather of a mixed competitive/non-competitive type, possibly due to the content of endogenous fatty acids (see later). Fig. 4 (0) When the platelet precipitate was extracted once more with Triton X-100 similar results were found, except that the total activity was lower in all peaks.
Partial purification of acyl-CoA synthetase on DEAE-Sepharose and Sephacryl S-200 HR Three protein peaks were eluted from the DEAE-Sepharose Fast Flow column. Peak II, which was eluted in 80 mM-potassium phosph'ate (pH 7.45)/50 /zM-ATP/5 mM-DTT/2 mM-Triton X-100, contained all of the acyl-CoA synthetase activity (Fig. 7a) . The specific activity for palmitoyl-CoA synthetase increased from 5 nmol/min per mg of protein in the Triton X-100 extract to 28 nmol/min per mg, and from 9 nmol/min per mg for arachidonoyl-CoA synthetase to 76 nmol/min per mg. The pooled concentrated fractions containing enzyme activity from the DEAE-Sepharose chromatography were applied to a Sephacryl S-200 HR column (Fig. 7b) . Although the enzyme was eluted in the void volume, the specific activities had increased to 37 nmol/min per mg of protein with palmitate as substrate and to 116 nmol/min per mg with arachidonate as substrate. This procedure resulted in purifications of respectively 8-and 12-fold for the two enzyme activities.
The fractions from Sephacryl chromatography containing enzyme activity were pooled, dialysed and applied to the CoASepharose 4B column. The enzyme activity was lost during this procedure. Shortening the dialysis time to 3.5 h did not preserve the enzyme activity. Therefore a Triton X-100 extract omitting DTT and ATP (Kameda et al., 1985) in the platelet suspension was centrifuged at 100000 gmax.. The supernatant was applied to the CoA-Sepharose 4B column. Two protein peaks were eluted, the first with the equilibration buffer, and the second with the KCI gradient buffer (results not shown). Acyl-CoA synthetase activity was found only in the first peak, and no separation of the palmitoyl-CoA and arachidonoyl-CoA synthetase activities was obtained.
Arachidonoyl-CoA synthetase and palmitoyl-CoA synthetase activities in eluates after chromatography on Sephadex G-100 followed by AcA 34 chromatography Both arachidonoyl-CoA and palmitoyl-CoA synthetase activities were eluted with the void volume by Sephadex G-100 chromatography (similar results were obtained with Sephacryl S-200 HR). In the peak fractions the activities were, however, increased by a factor of about 1.3 (Fig. 8a) . When the Diaflomembrane-filter concentrate from the Sephadex G-100 column was eluted from an AcA 34 column, both arachidonoyl-CoA and palmitoyl-CoA synthetase activities appeared together in two peaks with approximately the same ratio of activities with the two substrates (Fig. 8b) . The first, smaller, peak was eluted with the void volume. The third protein peak contained no activity.
The recovery of activity was low, only about 25 % for both substrates.
DISCUSSION
In the crude enzyme preparations used in these studies of fatty acyl-CoA synthetase(s), unspecific binding of added as well as endogenous fatty acids to platelet proteins and other cell components (Ockner & Manning, 1974) will cause a small overestimation of the measured Km values for the fatty acids. From Table 1 we can infer that the active sites of acyl-CoA synthetase have a strong affinity for the substrates.
The measurement of the fatty acid activation in this investigation is most probably without side-reactions, for the following 1991 (a) The column was eluted with 20 mM-potassium phosphate buffer containing 1 mM-ATP, 5 mM-DTT and 2 mM-Triton X-100, followed by 80 mM-phosphate buffer containing ATP, DTT and Triton X-100. Enzyme activities were assayed as described in the Materials and methods section. (b) The AcA 34 column was eluted with 100 mM-potassium phosphate buffer, pH 7.45, containing 1 mM-ATP and 5 mM-DTT. Enzyme activities were assayed as described in the Materials and methods section.
reasons.
(1) The mitochondria were disrupted when preparing the lysate, so sub-reactions such as f-oxidation are unlikely. (2) Platelet long-chain acyl-CoA hydrolase was inactive under the present conditions with 10 mm MgCl2 (Berge & Farstad, 1978) , and 1.6 mM-Triton X-100 would bind free acyl-CoA (Berge et al., 1981) , in agreement with McKean et al. (1982) . (3 (Fig. 2) . Also, the fatty acid activation pattern was almost the same in platelet lysates as in the dense-tubular-enriched fraction and the mitochondria-enriched fraction. Wilson et al. (1982) found that formation of arachidonoyl-CoA was four times faster than formation of oleoyl-CoA. These authors found an activity of 2.9 nmol/min per 109 platelets for arachidonic acid, whereas we found an activity of approx. almost 20 nmol/min per 109 platelets for arachidonic acid, and up to 50 nmol/min per mg in a dense-tubular-enriched fraction (Fig. 2) Wilson et al. (1982) measured the acyl-CoA synthetase activity in isolated platelet membranes, which are supposed to be a purer source of the enzyme than are platelet lysates. In a later work, however, workers in the same laboratory (Neufeld et al., 1984) reported a Km value for arachidonate of 12 /M.
Acyl-CoA synthetase in platelet lysates is stimulated by Triton X-100 with a maximal activity at 0.1 % or about 1.6 mM-Triton X-100 (Vollset & Farstad, 1979; Berge et al., 1981; Bakken, 1986) , which was used in the present work. As the CMC for Triton X-100 in the incubation mixture at 37°C is probably less than 0.01 0%, or about 80 /LM (Berge et al., 1981) , the fatty acid substrates were present in mixed micelles at all concentrations tested (molar ratio of fatty acid/Triton X-100 from 1:10 to 1:250).
The mean concentration of free CoA in platelets in vivo is [8] [9] [10] IuM (Ingebretsen et al., 1982b) (1982) , that platelet membranes prepared by sonication had more than one long-chain acyl-CoA synthetase. On the other hand, purified long-chain acyl-CoA synthetases from both mitochondria and microsomes of rat liver showed a broad specificity with approximately the same specific activity for palmitate and arachidonate (Tanaka et al., 1979) . Laposata et al. (1985) reported separation of a specific arachidonoyl-CoA synthetase from an unspecific enzyme by hydroxyapatite chromatography. In our experiments both palmitoyl-CoA and arachidonoyl-CoA synthetase activities were eluted together, with a near-constant ratio of activities after chromatography on hydroxyapatite, DEAE-Sepharose followed by Sephacryl S-200 HR, CoA-Sepharose 4B, and Sephadex G-100 followed by AcA 34 (Figs. 6, 7 and 8) . Noy & Zakim (1985) presented their fatty acid substrates in phosphatidylcholine liposomes, and obtained activities twice as high as those recorded in the present work, where Triton X-100 was used. However, the addition of various fatty acids in the form of liposomes would result in co-variations of the concentrations of phosphatidylcholine liposomes with the concentrations of the fatty acid substrate. Phosphatidylcholine is a substrate for the CoA-dependent transacylation of platelet phospholipids (Kramer et al., 1984) . Also, variations of non-esterified fatty acids in liposomes are not straightforward in experiments for determination of apparent Km values. We therefore chose an approach using a constant concentration of Triton X-100, thus ensuring that all substrates were added under identical conditions. We are aware that the presence of Triton X-100 in the elution buffers resulted in ineffective separation by gel filtration. This is most likely due to micelle-like complexes of active enzyme, resembling the effects observed with long-chain acyl-CoA hydrolase (Berge et al., 1981) . In spite of this, gel filtration with Sephacryl S-200 HR resulted in a significant purification (12-and 8-fold respectively) of the activity with both ['4C]arachidonate and [14C]palmitate as substrate (see Fig. 7b ). Some purification was also obtained by chromatography on Sephadex G-100 followed by AcA 34 when Triton was omitted from the elution buffer (see Fig. 8 ).
The present results differ to a great extent from the results reported from Majerus' group (Wilson et al., 1982; Majerus et al., 1983; Neufeld et al., 1984; Laposata et al., 1985) . Whereas these workers have reported the existence of an acyl-CoA synthetase specific for arachidonic acid and other prostanoid precursors, the present results indicate that palmitoyl-CoA (or unspecific) synthetase and arachidonoyl-CoA (or specific) synthetase are the same enzyme. This assumption is based on the following facts. (1) (Bakken & Farstad, 1989) . (6) PalmitoylCoA synthetase and arachidonoyl-CoA synthetase from the Triton X-100 extract of human platelet lysates were eluted in almost the same proportions and in the same protein peaks in six different chromatographic systems: hydroxyapatite, DEAESepharose, Sephacryl S-200 HR, CoA-Sepharose 4B, Sephadex G-100 and AcA 34. (7) Partial purification ofacyl-CoA synthetase (Fig. 7b) resulted in protein peaks with very high activities with both arachidonate and palmitate as substrates (purification factors of 12-and 8-fold respectively).
